Annual report pursuant to Section 13 and 15(d)

13. SEGMENT INFORMATION (Details)

v3.7.0.1
13. SEGMENT INFORMATION (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Product sales, net $ 11,060,636 $ 11,529,402
Gross profit 6,997,635 6,730,984
Gain on collection of related party notes receivable 379,486 0
Gain on change in derivative liability 147,200 0
Impairment of inventory (3,562,459) 0
Impairment of PhytoSPHERE goodwill and intangible assets 2,746,512 0
Litgation settlement income 0 756,714
Selling, general and administrative (13,129,950) (17,377,282)
Research and development (1,159,009) (1,320,003)
Operating (loss) income (13,073,609) (11,209,587)
Consumer Products [Member]    
Product sales, net 11,060,636 11,529,402
Gross profit 6,997,635 6,730,984
Gain on collection of related party notes receivable 379,486  
Gain on change in derivative liability 147,200  
Impairment of inventory (3,562,459)  
Impairment of PhytoSPHERE goodwill and intangible assets (2,746,512)  
Litgation settlement income   756,714
Selling, general and administrative 1,274,121 (17,377,282)
Research and development (834,963) (1,320,003)
Operating (loss) income (12,360,824) (11,209,587)
Specialty Pharmaceuticals [Member]    
Product sales, net 0 0
Gross profit 0 0
Gain on collection of related party notes receivable 0  
Gain on change in derivative liability 0  
Impairment of inventory 0  
Impairment of PhytoSPHERE goodwill and intangible assets 0  
Litgation settlement income   0
Selling, general and administrative (388,739) 0
Research and development (324,046) 0
Operating (loss) income $ (712,785) $ 0